ESR1 and breast cancer: Gene expression profiling has also revealed that high CEACAM5 expression predicts poor outcomes in estrogen receptor (ER)‐positive breast cancer, while low CEACAM5 expression is linked to poor survival in basal‐like breast cancer [39].